Literature DB >> 35372761

Improving stroke pathways using an adhesive ambulatory ECG patch: reducing time for patients to ECGs and subsequent results.

Alex Lang1, Chandra Basyal2, Matthew Benger2, Ajay Bhalla3, Faye Edwards1, Mena Farag2, Naveen Gadapa2, Yi-Yen K Kee4, Seemin Mahmood4, Laura Semple1, Peter Sommerville3, Angela Roots3, James Teo2, Rosie Wright2, Helen Williams1.   

Abstract

Three south-London hospital trusts undertook a feasibility study, comparing data from 93 patients who received the 14-day adhesive ambulatory electrocardiography (ECG) patch Zio XT with retrospective data from 125 patients referred for 24-hour Holter for cryptogenic stroke and transient ischaemic attack following negative 12-lead ECG. As the ECG patch was fitted the same day as the clinical decision for ambulatory ECG monitoring was made, median time to the patient having the monitor fitted was significantly reduced in all three hospital trusts compared with 24-hour Holter being ordered and fitted. Hospital visits reduced by a median of two for patients receiving Zio XT. This project supports that it is feasible to use a patch as part of routine clinical care with a positive impact on care pathways. © Royal College of Physicians 2022. All rights reserved.

Entities:  

Keywords:  adhesive ambulatory ECG patch; atrial fibrillation; stroke

Year:  2022        PMID: 35372761      PMCID: PMC8966802          DOI: 10.7861/fhj.2021-0151

Source DB:  PubMed          Journal:  Future Healthc J        ISSN: 2514-6645


  2 in total

1.  Embolic strokes of undetermined source: the case for a new clinical construct.

Authors:  Robert G Hart; Hans-Christoph Diener; Shelagh B Coutts; J Donald Easton; Christopher B Granger; Martin J O'Donnell; Ralph L Sacco; Stuart J Connolly
Journal:  Lancet Neurol       Date:  2014-04       Impact factor: 44.182

2.  Early prolonged ambulatory cardiac monitoring in stroke (EPACS): an open-label randomised controlled trial.

Authors:  Amit Kaura; Laszlo Sztriha; Fong Kum Chan; John Aeron-Thomas; Nicholas Gall; Bartlomiej Piechowski-Jozwiak; James T Teo
Journal:  Eur J Med Res       Date:  2019-07-26       Impact factor: 2.175

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.